3303 MONTE VILLA PARKWAY, BOTHELL, WA
BioLife Solutions Completes Acquisition by Repligen Corporation
Other Events
Reports Second Quarter 2026 Financial Results
President and CEO Shares Enthusiasm for Pending Transaction
Investor Presentation
Reports First Quarter 2026 Financial Results
Q2
Q1
Amended Annual Report
FY 2025
Q3
Prospectus Filed Pursuant to Rule 425
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Merger Proxy Statement
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
S-8 POS
Post-Effective Amendment to Registration Statement